Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Oates

Showing results (181-190 of 238) with videos related to

Pageof 24
Sort By:
Antioxidants & Redox Signaling|July 24, 2009
Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidationYasuo Ido, Jens R Nyengaard, Kathy Chang, et al.
Medical Education|September 1, 1989
Setting educational priorities for learning the concepts of population healthP J MacDonald, J P Chong, P Chongtrakul, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2008
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapyAlexandra Leary, L Assersohn, D Cunningham, et al.
The Journal of Nutrition, Health & Aging|December 8, 2016
DG Connect Funded Projects on Information and Communication Technologies (ICT) for Old Age People: Beyond Silos, CareWell and SmartCareW Keijser, E de Manuel-Keenoy, M d'Angelantonio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancerP Ross, A Norman, D Cunningham, et al.
Diabetologia|January 27, 2011
Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 miceH Liu, Y Luo, T Zhang, et al.
British Journal of Cancer|April 28, 2005
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancerS Rao, D Cunningham, R E Hawkins, et al.
Journal of Clinical Pharmacology|March 12, 2010
Pharmacokinetics, pharmacodynamics, tolerability, and safety of a novel sorbitol dehydrogenase inhibitor in healthy participantsZohar Landau, Mark J Novotny, Gregory M Preston, et al.
Journal of the American Geriatrics Society|October 8, 2009
Multisite geriatrics clerkship for fourth-year medical students: a successful model for teaching the Association of American Medical Colleges' core competenciesDaniel J Oates, Lisa E Norton, Matthew L Russell, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|June 12, 2012
Minimizing geriatric rehospitalizations: a successful modelDaniel J Oates, David Kornetsky, Michael R Winter, et al.
Pageof 24

Showing results (181-190 of 238) with videos related to

Sort By:
Pageof 24
Antioxidants & Redox Signaling|July 24, 2009
Early neural and vascular dysfunctions in diabetic rats are largely sequelae of increased sorbitol oxidationYasuo Ido, Jens R Nyengaard, Kathy Chang, et al.
Medical Education|September 1, 1989
Setting educational priorities for learning the concepts of population healthP J MacDonald, J P Chong, P Chongtrakul, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2008
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapyAlexandra Leary, L Assersohn, D Cunningham, et al.
The Journal of Nutrition, Health & Aging|December 8, 2016
DG Connect Funded Projects on Information and Communication Technologies (ICT) for Old Age People: Beyond Silos, CareWell and SmartCareW Keijser, E de Manuel-Keenoy, M d'Angelantonio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancerP Ross, A Norman, D Cunningham, et al.
Diabetologia|January 27, 2011
Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 miceH Liu, Y Luo, T Zhang, et al.
British Journal of Cancer|April 28, 2005
Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancerS Rao, D Cunningham, R E Hawkins, et al.
Journal of Clinical Pharmacology|March 12, 2010
Pharmacokinetics, pharmacodynamics, tolerability, and safety of a novel sorbitol dehydrogenase inhibitor in healthy participantsZohar Landau, Mark J Novotny, Gregory M Preston, et al.
Journal of the American Geriatrics Society|October 8, 2009
Multisite geriatrics clerkship for fourth-year medical students: a successful model for teaching the Association of American Medical Colleges' core competenciesDaniel J Oates, Lisa E Norton, Matthew L Russell, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|June 12, 2012
Minimizing geriatric rehospitalizations: a successful modelDaniel J Oates, David Kornetsky, Michael R Winter, et al.
Pageof 24